CONMED Corp. Stock
Price
Target price
?
?
-0.540%
-0.2
-0.540%
€47.79
08:10 / Frankfurt
WKN: 886793 / Symbol: CNMD / Name: CONMED / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
CONMED Corp. Stock
CONMED Corp. shows a slight decrease today, losing -€0.200 (-0.540%) compared to yesterday.
Our community is currently high on CONMED Corp. with 5 Buy predictions and 1 Sell predictions.
As a result the target price of 47 € shows a positive potential of 27.03% compared to the current price of 37.0 € for CONMED Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for CONMED Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of CONMED Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | -0.540% | 12.258% | 16.779% | -23.348% | -0.571% | -70.756% | -69.739% |
| Penumbra Inc | -0.290% | -0.432% | 0.655% | 36.323% | 3.829% | -2.606% | 22.389% |
| Glaukos Corp | -1.490% | -1.481% | 22.018% | 48.603% | 37.824% | 112.800% | 116.260% |
| Integra LifeSciences Holdings Corp | -1.230% | 2.532% | 6.579% | 45.946% | 52.830% | -57.592% | -71.579% |
Comments
CONMED (CNMD) had its "underperform" rating reaffirmed by Bank of America Corporation. They now have a $40.00 price target on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED (CNMD) was downgraded by Wall Street Zen from "strong-buy" to "buy".
Show more
Ratings data for CNMD provided by MarketBeat
CONMED (CNMD) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for CNMD provided by MarketBeat